Annex Advisory Services’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-21,769
Closed -$1.42M 130
2019
Q4
$1.42M Sell
21,769
-1,201
-5% -$78.2K 0.17% 62
2019
Q3
$1.46M Sell
22,970
-662
-3% -$43.3K 0.2% 57
2019
Q2
$1.6M Buy
23,632
+522
+2% +$34.3K 0.22% 52
2019
Q1
$1.5M Buy
23,110
+1,128
+5% +$75K 0.23% 56
2018
Q4
$1.38M Sell
21,982
-98
-0.4% -$6.85K 0.22% 59
2018
Q3
$1.71M Buy
22,080
+2,107
+11% +$159K 0.26% 50
2018
Q2
$1.42M Buy
19,973
+1,226
+7% +$86.6K 0.24% 52
2018
Q1
$1.41M Buy
+18,747
New +$1.49M 0.26% 46
2017
Q1
Sell
-4,029
Closed -$289K 121
2016
Q4
$289K Buy
4,029
+388
+11% +$28.8K 0.07% 93
2016
Q3
$288K Sell
3,641
-712
-16% -$57.8K 0.07% 88
2016
Q2
$363K Buy
4,353
+1,585
+57% +$141K 0.1% 84
2016
Q1
$254K Sell
2,768
-63
-2% -$5.68K 0.07% 95
2015
Q4
$287K Buy
2,831
+16
+0.6% +$1.67K 0.08% 92
2015
Q3
$276K Buy
+2,815
New +$313K 0.09% 94

Other funds holding GILD

Annex Advisory Services's GILD Position: Q1 2020 in Review

Annex Advisory Services sold out of Gilead Sciences (GILD) in Q1 2020, closing a stake of 21,769 shares — an estimated $1.42M sold.

Annex Advisory Services first reported a position in GILD in Q3 2015 and held it in 14 quarters. The position peaked at $1.71M in Q3 2018. 1,643 funds tracked by Wall St. Rank hold GILD as of Q1 2020.

  • Annex Advisory Services reported no remaining Gilead Sciences position as of Q1 2020 after selling out during the quarter.
  • Annex Advisory Services sold 21,769 Gilead Sciences shares in Q1 2020, an estimated $1.42M.
  • Annex Advisory Services first reported a position in Gilead Sciences in Q3 2015 and held it in 14 quarters.
  • Annex Advisory Services's Gilead Sciences position peaked at $1.71M in Q3 2018.
  • 1,643 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2020.

Based on Annex Advisory Services's 13F filing for Q1 2020, filed 22 Apr 2020.